| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9009580 | Journal of the American Pharmacists Association | 2005 | 13 Pages |
Abstract
Pharmacists should be cognizant of the potential for PDE5 inhibitors to be misused, particularly in patients who are at greater risk of cardiovascular complications, and should advise patients and other health care professionals accordingly.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Kelly M. (Associate Professor and Director), Frank (Associate Professor of Pharmacy and Clinical Specialist in HIV/AIDS),